Patents by Inventor Kyu Kwang Kim

Kyu Kwang Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4
    Publication number: 20230159586
    Abstract: The present disclosure provides compounds of Formula I for use in the treatment of medical disorders by the inhibition of human epididymal protein 4 (HE4).
    Type: Application
    Filed: April 21, 2021
    Publication date: May 25, 2023
    Inventors: Rakesh Singh, Richard Moore, Kyu Kwang Kim
  • Nitrofuran compounds for the treatment of cancer and angiogenesis
    Patent number: 9220714
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Grant
    Filed: May 17, 2013
    Date of Patent: December 29, 2015
    Assignees: Brown University, Women and Infants' Hospital Rhode Island
    Inventors: Giselle L. Saulnier Sholler, Narasimha Swamy, Stayan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim
  • NITROFURAN COMPOUNDS FOR THE TREATMENT OF CANCER AND ANGIOGENESIS
    Publication number: 20130331383
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Application
    Filed: May 17, 2013
    Publication date: December 12, 2013
    Applicants: BROWN UNIVERSITY, WOMEN AND INFANTS HOSPITAL OF RHODE ISLAND
    Inventors: Henna Swamy, Laurent Brard, Rakesh K. Singh, Satyan Kalkunte, Narasimha Swamy, Giselle L. Saulnier Sholler, Kyu Kwang Kim
  • Nitrofuran compounds for the treatment of cancer and angiogenesis
    Patent number: 8470815
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Grant
    Filed: March 7, 2007
    Date of Patent: June 25, 2013
    Assignees: Brown University, Women and Infants' Hospital Rhode Island
    Inventors: Giselle L. Saulnier Sholler, Satyan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim, Hena Swamy
  • N-amino tetrahydrothiazine derivatives, method of manufacture and use
    Patent number: 8193180
    Abstract: This invention comprises the innovative synthesis of N-amino tetrahydrothiazine free bases and their salts. This invention further comprises the use of the derivatives and their therapeutic application as anticancer agents. Further this invention comprises their manufacture and use.
    Type: Grant
    Filed: January 23, 2008
    Date of Patent: June 5, 2012
    Assignee: Women & Infants Hospital
    Inventors: Laurent Brard, Rakesh Kumar Singh, Kyu Kwang Kim, Giselle Saulnier-Sholler
  • Nitrofuran Compounds for the Treatment of Cancer and Angiogenesis
    Publication number: 20110288080
    Abstract: The invention is directed to the synthesis and use of nitrofuran compounds, especially Nifurtimox, as medicaments to treat cancer, especially neuroblastoma, and to inhibit angiogenesis. The invention also provides compositions, unit dosage forms, and kits comprising the compounds.
    Type: Application
    Filed: March 7, 2007
    Publication date: November 24, 2011
    Inventors: Giselle L Saulnier Sholler, Narasimha Swamy, Henna Swamy, Satyan Kalkunte, Rakesh K. Singh, Laurent Brard, Kyu Kwang Kim